A Pekel

Serum interleukin-18 levels in patients with Behçet’s disease. Is its expression associated with disease activity or clinical presentations?

Uğur Muşabak, S. Pay, Hakan Erdem et al. · Rheumatology International · 2005 · 68 citations

Veterinary Medicine, Immunology, Internal Medicine +13

Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?

S. Pay, TEYMUR ABBASOV, Hakan Erdem et al. · PubMed · 2008 · 38 citations

Medicine, Pathobiology, Pathology +14

Chimerical Anti-TNF-α, Infliximab, Inhibits Neutrophil Chemotaxis and Production of Reactive Oxygen Species by Blocking the Priming Effect of Mononuclear Cells on Neutrophils

S. Pay, Uğur Muşabak, Hatice Rana Erdem et al. · Immunopharmacology and Immunotoxicology · 2005 · 18 citations

Life Sciences, Immunology, Pharmacology +17

Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?

S. Pay, İsmail Şimşek, Husamettin Erdem et al. · PubMed · 2008 · 18 citations

Life Sciences, Immunology, Pathology +17

Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation.

S. Pay, A Pekel, İsmail Şimşek et al. · PubMed · 2010 · 11 citations

Life Sciences, Immunology, Pathology +16